Completed NA INTERVENTIONAL 2-arm NCT01918475

Analgesic Effect of Oxytocin Receptor Modulation

Analgesic Effect of Oxytocin Receptor Modulation in Healthy Volunteers

Sponsor: Insel Gruppe AG, University Hospital Bern

Conditions Central Sensitization Hyperalgesia Pain

Updated 6 times since 2017 Last updated: Feb 11, 2015 Started: Jul 31, 2013 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01918475, this NA trial focuses on Central Sensitization and Hyperalgesia and remains completed. Sponsored by Insel Gruppe AG, University Hospital Bern, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2023 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Jul 2023 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Insel Gruppe AG, University Hospital Bern

Data source: Insel Gruppe AG, University Hospital Bern

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bern, Switzerland